Cardinal Health, Inc. $CAH Shares Sold by BOK Financial Private Wealth Inc.

BOK Financial Private Wealth Inc. cut its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 18.1% in the 2nd quarter, Holdings Channel reports. The fund owned 6,763 shares of the company’s stock after selling 1,498 shares during the period. BOK Financial Private Wealth Inc.’s holdings in Cardinal Health were worth $1,136,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of CAH. Greykasell Wealth Strategies Inc. acquired a new position in shares of Cardinal Health in the 1st quarter valued at approximately $26,000. Jones Financial Companies Lllp increased its stake in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the last quarter. Atlantic Edge Private Wealth Management LLC raised its holdings in Cardinal Health by 75.0% in the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after acquiring an additional 75 shares in the last quarter. NewSquare Capital LLC boosted its stake in Cardinal Health by 100.0% during the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock valued at $36,000 after acquiring an additional 107 shares during the last quarter. Finally, GW&K Investment Management LLC grew its holdings in Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after acquiring an additional 144 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Wall Street Analyst Weigh In

CAH has been the topic of several research analyst reports. Mizuho increased their price target on shares of Cardinal Health from $170.00 to $210.00 and gave the stock an “outperform” rating in a research report on Monday, November 3rd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. TD Cowen boosted their price target on Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 3rd. Robert W. Baird set a $232.00 price objective on Cardinal Health in a research note on Friday, October 31st. Finally, Leerink Partners lifted their price objective on shares of Cardinal Health from $187.00 to $211.00 in a report on Friday, October 31st. Twelve investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $205.00.

Cardinal Health Stock Performance

CAH stock opened at $203.40 on Monday. Cardinal Health, Inc. has a 1 year low of $114.60 and a 1 year high of $203.67. The stock has a market capitalization of $48.33 billion, a price-to-earnings ratio of 31.53, a PEG ratio of 1.39 and a beta of 0.72. The stock’s fifty day moving average is $160.02 and its two-hundred day moving average is $156.87.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion for the quarter, compared to analysts’ expectations of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company’s revenue for the quarter was up 22.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a dividend of $0.5107 per share. The ex-dividend date is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s payout ratio is currently 30.77%.

Insiders Place Their Bets

In related news, CEO Jason M. Hollar sold 107,705 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.90, for a total value of $16,037,274.50. Following the sale, the chief executive officer directly owned 235,901 shares in the company, valued at $35,125,658.90. This trade represents a 31.35% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the sale, the insider directly owned 15,431 shares in the company, valued at $2,298,293.14. The trade was a 64.59% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is owned by company insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.